(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
People aged 18 to 65 who have schizophrenia may qualify for this study. Participants will receive study medication and labs, and may be reimbursed for time and travel.
The research site is in Glendale, Ariz.
This study will evaluate any visual field changes in people taking pregabalin as an add-on therapy for partial epilepsy.
The research site is in Charleston, S.C.
This study will evaluate an investigational medication for depression. People who qualify will receive study related evaluation and care at no cost, and a stipend for time and travel.
The research site is in Norristown, Penn.
Copyright 2009ClinicalConnection.com. All rights reserved.